Literature DB >> 31850564

Commentary: estimating the prevalence of IBS globally-past, present and future.

Alexander C Ford1,2.   

Abstract

Mesh：

Year:  2020        PMID： 31850564     DOI： 10.1111/apt.15508

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  2 in total

1.  Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders.

Authors:  Tenghao Zheng; Nicholas A Kennedy; Chris Eijsbouts; Ferdinando Bonfiglio; Carl A Anderson; Loukas Moutsianas; Joanne Holliday; Jingchunzi Shi; Suyash Shringarpure; Alexandru-Ioan Voda; Gianrico Farrugia; Andre Franke; Matthias Hübenthal; Gonçalo Abecasis; Matthew Zawistowski; Anne Heidi Skogholt; Eivind Ness-Jensen; Kristian Hveem; Tõnu Esko; Maris Teder-Laving; Alexandra Zhernakova; Michael Camilleri; Guy Boeckxstaens; Peter J Whorwell; Robin Spiller; Gil McVean; Mauro D'Amato; Luke Jostins; Miles Parkes
Journal:  Nat Genet       Date:  2021-11-05       Impact factor: 38.330

2.  External therapy of traditional Chinese medicine for treating irritable bowel syndrome with diarrhea: A systematic review and meta-analysis.

Authors:  Xiuxiu Wei; Yongtian Wen; Yuchen Wei; Xu Liang; Xiangxue Ma; Beihua Zhang; Xudong Tang
Journal:  Front Med (Lausanne)       Date:  2022-08-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.